QI
ITRM

QS Investors’s Iterum Therapeutics ITRM Stock Holding History

QS Investors’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$888K Buy
+25,613
New +$555K 0.01% 525

Other funds holding ITRM

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QS Investors's ITRM Position: Q2 2021 in Review

QS Investors opened a new position in Iterum Therapeutics (ITRM) in Q2 2021: 25,613 shares worth $888K. The stake represents 0.01% of the portfolio and ranks #525 among its holdings.

44 funds tracked by Wall St. Rank hold ITRM as of Q2 2021.

  • QS Investors held 25,613 shares of Iterum Therapeutics worth $888K as of Q2 2021.
  • Iterum Therapeutics was a new QS Investors position in Q2 2021.
  • Iterum Therapeutics made up 0.01% of QS Investors's portfolio in Q2 2021, its #525 holding.
  • 44 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.